Bexion Pharmaceuticals advances clinical development of BXQ-350 in rare pediatric tumors
NKyTribune staff Covington-based Bexion Pharmaceuticals, Inc. an oncology-focused company, has announced the completion of a Type B Pre-IND in-person meeting…
Jenn Highfield
Read More
‘I Thought It Was a Miracle’ – Clinical trial using Bexion BXQ-350 works wonders for Markey patient
By Allison Perry University of Kentucky Despite the leaps and advances made in cancer treatments over the past few decades,…